Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Analytical Reproducibility of the Spartan FRX CYP2C19 *2,*3 and *17 Genotyping System.

NCT01676298 is registered in ClinicalTrials.gov with Spartan Bioscience Inc. as lead sponsor.

NCT NCT01676298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01676298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Analytical Reproducibility of the Spartan FRX CYP2C19 *2,*3 and *17 Genotyping System.
Lead sponsor
Spartan Bioscience Inc.
Phase
Observational
Overall status
Completed
Start date
August 31, 2012
Completion date
November 30, 2012
Enrollment
8 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

analytical reproducibility of a medical device